Marijuana firm MedMen closes initial $80 million in funding from Gotham Green

Be at the forefront of the latest cannabis scientific research. Submit a research abstract to present by Dec. 16, or register to attend the The Emerald Conference by MJBizScience, March 1-3 in San Diego.

 


MedMen, a multistate cannabis company based in California, said it closed on an initial $80 million tranche of funding from New York private equity group Gotham Green Partners (GGP).

The money is the first part of a $250 million convertible credit facility with GGP that MedMen secured in March.

More details on the funding can be found here.

MedMen, which trades under the ticker symbol MMEN on the Canadian Securities Exchange, will release its quarterly results May 29.